Trials / Conditions / Propionic Acidemia

Propionic Acidemia

17 registered clinical trials studyying Propionic Acidemia — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Retrospective Study to Characterize Participants With Propionic Acidemia NCT05769621	ModernaTX, Inc.	—
Completed	Baby Detect : Genomic Newborn Screening NCT05687474	Centre Hospitalier Universitaire de Liege	—
Recruiting	An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics NCT05040178	RECORDATI GROUP	—
Recruiting	A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled NCT05130437	ModernaTX, Inc.	Phase 1 / Phase 2
Terminated	Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia NCT05438485	HemoShear Therapeutics	—
Recruiting	Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia NCT04159103	ModernaTX, Inc.	Phase 1 / Phase 2
Terminated	A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Voluntee NCT04836494	CoA Therapeutics, Inc., a BridgeBio company	Phase 1
Terminated	Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia NCT04732429	HemoShear Therapeutics	Phase 2
Recruiting	Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach NCT04176523	RECORDATI GROUP	—
Enrolling By Invitation	Early Check: Expanded Screening in Newborns NCT03655223	RTI International	—
Completed	"The MaP Study": Mapping the Patient Journey in MMA and PA NCT03484767	ModernaTX, Inc.	—
Completed	Review of Charts From Amish/Mennonite Variant PA Patients NCT03159026	University of Pittsburgh	—
Recruiting	Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia NCT02890342	National Human Genome Research Institute (NHGRI)	—
Completed	Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia NCT02426775	King Abdullah International Medical Research Center	Phase 3
Terminated	Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia NCT01597440	Mendel Tuchman	Phase 2
Withdrawn	Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate NCT01341379	Children's Hospital of Philadelphia	Phase 2
Completed	Anaplerotic Therapy in Propionic Acidemia NCT00645879	Nicola Longo	Phase 1